Championing global health equity, advancing environmental health and empowering its employees to be their best are just some of the ways Johnson & Johnson is working to help improve the well-being of people around the world. The company's 2021 Health for Humanity Report reveals just how far it's come toward these ambitious goals.
Tackling health inequities. Pinpointing the sources of pain. Helping the immune system target cancer. These are just some of the ambitious goals of the companies residing at Johnson & Johnson's newest incubator, JLABS @ Washington, DC. Meet three healthcare innovators leading the way.
Injections that allow people with schizophrenia to go longer between treatments. Digital tools that may lead to the creation of more effective medications. Programs that ensure mental illness is properly diagnosed. These are just a few of the ways Johnson & Johnson is addressing the largest unmet need in healthcare.
Their innovative ideas hold promise in solving two of healthcare’s most vexing problems: the nursing shortage and wound care. And Johnson & Johnson is helping them make their high-tech dreams a reality.
Algorithms, artificial intelligence, machine learning and other technologies are transforming the way physicians identify, treat and manage diseases. Here’s how Johnson & Johnson is putting the latest tools to work.
That's exactly what researchers at Johnson & Johnson are trying to find out. By partnering on a new study that's looking at the role gut microbes may play in the disease—and focusing on the underrepresented groups most affected—they hope to advance early-detection strategies and potential treatments.
Healthcare providers who contracted TB on the job. A microbiologist researching new treatments. An activist ensuring attention is paid to one of the world’s greatest health threats. These young leaders share one goal: to help end TB.
In many cases, it can take more than two years to diagnose this rare disease—and that delay can be deadly. Johnson & Johnson is on a mission to identify patients earlier by harnessing the power of artificial intelligence, smartphone apps and more.
Hidden in large amounts of digital information—such as anonymized medical records—may be the keys to transforming the future of healthcare. Troy C. Sarich, Ph.D., Johnson & Johnson's Chief Commercial Data Science Officer, shares how the company is carefully collecting, analyzing and harnessing this information to improve the health of people everywhere.
In September of 2021, 250 innovators came together to address one of the United States’ most urgent challenges: mothers dying from pregnancy complications. Learn about their ideas to help improve health equity.
How can you tell which virus is causing your cough or fever? Is it too late to get a flu shot if you haven't? A Johnson & Johnson expert addresses these questions—and how the company is working to improve the future of flu prevention.
Respiratory syncytial virus (RSV) is normally rampant in winter—but the pandemic has changed the behavior of this common and potentially dangerous infection. Here's how to protect your family this season, and learn how Johnson & Johnson is working to keep us all safer from RSV.